See more : Greencity Acquisition Corporation (GRCYU) Income Statement Analysis – Financial Results
Complete financial analysis of NanoLogix, Inc. (NNLX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NanoLogix, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Jullundur Motor Agency (Delhi) Limited (JMA.NS) Income Statement Analysis – Financial Results
- PT Perusahaan Gas Negara Tbk (PPAAF) Income Statement Analysis – Financial Results
- Star Gold Corp. (SRGZ) Income Statement Analysis – Financial Results
- SERA INVESTMENTS & FINANCE IND (SERA.BO) Income Statement Analysis – Financial Results
- Al-Razi Medical Co. (9572.SR) Income Statement Analysis – Financial Results
NanoLogix, Inc. (NNLX)
About NanoLogix, Inc.
NanoLogix, Inc., a biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. The company's products include BioNanoPore kit, which employs a water permeable membrane that works with organic and inorganic molecules, as well as proteins; and FlatPack Petri Plates that are used for the isolation and cultivation of various fastidious and non-fastidious microorganisms, as well as displays growth of aerobic and anaerobic microorganisms. Its products are used in medical, national defense, homeland security, pharmaceutical, industrial, veterinary, and environmental testing applications. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. NanoLogix, Inc. is based in Hubbard, Ohio.
Source: https://incomestatements.info
Category: Stock Reports